Temporary Staff

Research Group Home Page: 

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE

CamGFR v2: a new model for estimating the glomerular filtration rate from standardized or non-standardized creatinine in patients with cancer.

E-pub date: 30 Nov 2020

CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.

E-pub date: 30 Sep 2020

Detection of ctDNA from Dried Blood Spots after DNA Size Selection.

E-pub date: 31 Mar 2020

Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.

E-pub date: 31 Jan 2020

Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: a case report.

E-pub date: 31 Dec 2019

Multicenter Validation of the CamGFR Model for Estimated Glomerular Filtration Rate.

E-pub date: 01 Dec 2019

Improved ctDNA detection in early stage non-small-cell lung cancer

E-pub date: 01 Jul 2019

Cancer Immunotherapy Trials Underutilize Immune Response Monitoring.

E-pub date: 31 Jan 2018

Activating HER2 mutations as emerging targets in multiple solid cancers.

E-pub date: 01 Aug 2017

Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes.

E-pub date: 01 Jul 2017

Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity.

E-pub date: 08 Nov 2016

Medical student perceptions of research and research-orientated careers: An international questionnaire study.

E-pub date: 01 Oct 2016

Evaluation of liquid biopsies for molecular profiling and monitoring in non-small cell lung cancer (NSCLC) patients.

E-pub date: 30 Apr 2016

Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data.

E-pub date: 16 Feb 2016

RAD51 and BRCA2 Enhance Oncolytic Adenovirus Type 5 Activity in Ovarian Cancer.

E-pub date: 01 Jan 2016

Assessment of clinical applications of circulating tumor DNA using an enhanced TAm-Seq platform

E-pub date: 31 Jul 2015

Assessment of clinical applications of circulating tumor DNA using an enhanced TAm-Seq platform.

E-pub date: 30 Apr 2015

Proffered Paper: Noninvasive monitoring of tumour mutations and dynamics in circulating DNA of non-small cell lung cancer patients treated with EGFR inhibitors

E-pub date: 01 Jul 2014

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.

E-pub date: 10 Dec 2013

Non-invasive Monitoring of Metastatic Breast Cancer by Circulating Tumour DNA – a Comparison With Circulating Tumour Cells

E-pub date: 01 Jul 2012

Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells.

E-pub date: 01 Apr 2011

Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer.

E-pub date: 31 Oct 2010

Show all